<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="activity_corpus\PMC7571078\results\search\plant_compound\results.xml">
  <result pre="one of the main compounds of thyme essential oil. Both" exact="thymol" post="and thyme essential oil have long been used in"/>
  <result pre="and create opportunities for their extensive use. Extensive application of" exact="thymol" post="and thyme essential oil in the healthcare sector is"/>
  <result pre="sector is very promising but requires further research and analysis." exact="thymol" post="thyme essential oil new therapeutic applications 1. Introduction The"/>
  <result pre="with 12 mL/kg of minimum essential oil (EO) and minimum" exact="thymol" post="and carvacrol contents of 40% [2]. Thyme EO is"/>
  <result pre="mL/kg of minimum essential oil (EO) and minimum thymol and" exact="carvacrol" post="contents of 40% [2]. Thyme EO is defined as"/>
  <result pre="of one or a mixture of both species with 37â€&quot;55%" exact="thymol" post="and 0.5â€&quot;5.5% carvacrol concentrations [2,3]. The thyme herb, EO,"/>
  <result pre="a mixture of both species with 37â€&quot;55% thymol and 0.5â€&quot;5.5%" exact="carvacrol" post="concentrations [2,3]. The thyme herb, EO, and their main"/>
  <result pre="such as flavonoid glycosides, caffeic acid oligomers, simple phenolic acids," exact="hydroquinone" post="derivatives, and terpenoids should also be taken into account."/>
  <result pre="the main component of EO, but only â€œthymol typeâ€� with" exact="thymol" post="as the main constituent is listed in the European"/>
  <result pre="main components of thyme EO are the isomeric phenolic monoterpenes" exact="thymol" post="(2-isopropyl-5-methylphenol) and carvacrol (2-methyl-5-(propan-2-yl)phenol). Both these monoterpenes are biosynthesized"/>
  <result pre="thyme EO are the isomeric phenolic monoterpenes thymol (2-isopropyl-5-methylphenol) and" exact="carvacrol" post="(2-methyl-5-(propan-2-yl)phenol). Both these monoterpenes are biosynthesized by the hydroxylation"/>
  <result pre="(2-methyl-5-(propan-2-yl)phenol). Both these monoterpenes are biosynthesized by the hydroxylation of" exact="p-cymene" post="after the aromatization of Î³-terpinene to p-cymene. The scheme"/>
  <result pre="soluble in ethanol, acetone, and diethyl ether and with a" exact="thymol" post="odor [9]. Structures of thymol, carvacrol, and other thyme"/>
  <result pre="within 24 h. It is found in the form of" exact="thymol" post="sulfate in plasma, and two phase II conjugatesâ€&quot;thymol sulfate"/>
  <result pre="sulfate in plasma, and two phase II conjugatesâ€&quot;thymol sulfate and" exact="thymol" post="glucuronideâ€&quot;can be found in the urine. The formation of"/>
  <result pre="are presented in Figure 3. Oral bioavailability referred to as" exact="thymol" post="sulfate is approximately 16% and the plasma half-life is"/>
  <result pre="approximately 1.5 h [10,11]. The bioactivity and toxicological actions of" exact="carvacrol" post="were described by Sharifi and co-workers [9]. Thyme herb"/>
  <result pre="biological and pharmacological activities includes commonly known natural substances, including" exact="thymol" post="and thyme EO. This review presents selected directions of"/>
  <result pre="newer pharmaceutical forms that increase the bioavailability and activity of" exact="thymol" post="and thyme oil. 2. Activity against Microbiological Biofilms Antibiotic"/>
  <result pre="with the polar part of the membrane, while the hydrophobic" exact="benzene" post="ring and aliphatic side chains sink into the inner"/>
  <result pre="as enzymes and receptors. After incorporation into the cell membrane," exact="thymol" post="interacts with its embedded proteins through various non-specific mechanisms,"/>
  <result pre="isolated MRSA. It was found that thyme EO, which contained" exact="thymol" post="as a main ingredient, showed better growth-inhibiting properties for"/>
  <result pre="EO. Zhongwei and co-workers [38] also evaluated the effect of" exact="thymol" post="on MRSA biofilm and the potential synergy of thymol"/>
  <result pre="of thymol on MRSA biofilm and the potential synergy of" exact="thymol" post="with vancomycin, which is the antibiotic of choice for"/>
  <result pre="to neutral solid surfaces, which determines antibiotic resistance [39,40]. Neither" exact="thymol" post="nor vancomycin applied to MRSA colonies in the biofilm"/>
  <result pre="live bacteria was significantly reduced (Figure 4), which suggests that" exact="thymol" post="is effective in supporting the therapeutic effect of vancomycin"/>
  <result pre="main selected compounds from themâ€&quot;trans-cinnamaldehyde, terpinen-4-ol and thymol. Among them," exact="thymol" post="showed the most potent activity against single-species biofilms of"/>
  <result pre="of 0.2 mg/mL. The destructive effect of thyme EO and" exact="thymol" post="on E. coli, S. aureus, L. monocytogenes and P."/>
  <result pre="aeruginosa, which was probably also associated with the presence of" exact="thymol" post="as a main EO component. Biofilm reduction of 44.8%"/>
  <result pre="main component responsible for these antibacterial properties was thymol. Pure" exact="thymol" post="(5 Âµg/mL) has also been tested and its biofilm"/>
  <result pre="on cell viability has been observed using thyme EO and" exact="thymol" post="with ciprofloxacin. The use of the EO allowed the"/>
  <result pre="study results suggest that the combination of thyme EO or" exact="thymol" post="with this antibiotic could reduce its possible toxic effects"/>
  <result pre="used: thymol, carvacrol, eugenol, citral, cinnamaldehyde, and menthol. Thymol and" exact="carvacrol" post="proved to have the best antifungal effect, which inhibited"/>
  <result pre="forms in lower minimum inhibitory concentration (MIC) in comparison to" exact="thymol" post="and carvacrol. However, the biofilm-eradicating concentrations of those drugs"/>
  <result pre="32â€&quot;64 times higher than the MIC for planktonic forms, while" exact="thymol" post="and carvacrol were effective for biofilm reduction at concentrations"/>
  <result pre="higher than the MIC for planktonic forms, while thymol and" exact="carvacrol" post="were effective for biofilm reduction at concentrations 4â€&quot;8 higher"/>
  <result pre="neoformans and C. laurentii biofilm was much more sensitive to" exact="thymol" post="or carvacrol compared to standard therapies. The study also"/>
  <result pre="C. laurentii biofilm was much more sensitive to thymol or" exact="carvacrol" post="compared to standard therapies. The study also revealed that"/>
  <result pre="deformed and perforated outer cell membrane caused by penetration of" exact="thymol" post="into the outer layer of the cell membrane leads"/>
  <result pre="level may have antifungal activity. The probable antifungal mechanism of" exact="thymol" post="is based on the effect on fatty acid metabolism,"/>
  <result pre="found in lipids of plant and animal origin. Thymol or" exact="carvacrol" post="in combination with caprylic acid has synergistic antifungal activity"/>
  <result pre="plant and animal origin. Thymol or carvacrol in combination with" exact="caprylic acid" post="has synergistic antifungal activity [56]. The mechanism of antifungal"/>
  <result pre="mechanism of antifungal activity is associated with the ability of" exact="caprylic acid" post="to be incorporated into the lipid layer, which increases"/>
  <result pre="albicans was obtained during a few minutesâ€™ of exposure to" exact="caprylic acid" post="(1â€&quot;1.5 mM) with thymol or carvacrol (0.5â€&quot;1.5 mM). This"/>
  <result pre="few minutesâ€™ of exposure to caprylic acid (1â€&quot;1.5 mM) with" exact="thymol" post="or carvacrol (0.5â€&quot;1.5 mM). This combination made it possible"/>
  <result pre="of exposure to caprylic acid (1â€&quot;1.5 mM) with thymol or" exact="carvacrol" post="(0.5â€&quot;1.5 mM). This combination made it possible to reduce"/>
  <result pre="This combination made it possible to reduce the dose of" exact="caprylic acid," post="and thus possible toxic effects. The synergism of these"/>
  <result pre="(Meglumine antimoniate). An inhibitory effect on L. infantum growth after" exact="thymol" post="and carvacrol use was demonstrated. In vivo studies have"/>
  <result pre="An inhibitory effect on L. infantum growth after thymol and" exact="carvacrol" post="use was demonstrated. In vivo studies have shown in"/>
  <result pre="demonstrated. In vivo studies have shown in groups treated with" exact="thymol" post="not only a decrease of the presence of L."/>
  <result pre="compared to other groups studied. Cytotoxicity studies have shown that" exact="thymol" post="was a safer substance than other tested monoterpenoids. The"/>
  <result pre="a safer substance than other tested monoterpenoids. The mechanism of" exact="thymol" post="activity, as in the case of bacteria or fungi,"/>
  <result pre="membrane permeability regulation. However, the actual mechanism of action of" exact="thymol" post="and other EO components for these parasites has not"/>
  <result pre="for these parasites has not been confirmed yet. Thymol and" exact="carvacrol" post="appear to be promising, safe, and effective alternatives to"/>
  <result pre="of disinfectants with evidence for use against COVID-19 preparations with" exact="thymol" post="as the active ingredient. These products are designed to"/>
  <result pre="and co-workers [75] studied the antiproliferative and proapoptotic properties of" exact="thymol" post="on non-small-cell lung carcinoma, highly metastatic breast adenocarcinoma, and"/>
  <result pre="It is most likely associated with hydrophobic properties of the" exact="thymol" post="molecule and the ability to increase cancer cell plasma"/>
  <result pre="permeability. The research team led by Kang [76] found that" exact="thymol" post="inhibits cell growth and induces apoptosis in gastric adenocarcinoma"/>
  <result pre="and induces apoptosis in gastric adenocarcinoma cells. The cytotoxic, dose-dependent" exact="thymol" post="effect on tumor cells decreased their viability from 89.56"/>
  <result pre="h of exposure to this monoterpene. It was observed that" exact="thymol" post="induced significant morphological changes such as lower cell density,"/>
  <result pre="fragmentation of cell nuclei, and chromatin condensation. The use of" exact="thymol" post="caused an increase in the number of cells in"/>
  <result pre="which is a characteristic feature of apoptosis. Another mechanism of" exact="thymol" post="cytotoxic activity is the induction of reactive oxygen species"/>
  <result pre="co-workers [77] confirmed the cytotoxic, genotoxic, and proapoptotic effects of" exact="thymol" post="on gastric adenocarcinoma cells. These cell lines were treated"/>
  <result pre="on gastric adenocarcinoma cells. These cell lines were treated with" exact="thymol" post="in concentrations of 10, 20, 30, 50, 100, 200,"/>
  <result pre="Î¼M, prepared from a stock solution of 600 Î¼M of" exact="thymol" post="in dimethyl sulfoxide (DMSO), and after 24 h of"/>
  <result pre="a concentration of 50 Î¼M. Investigation of the effect of" exact="thymol" post="at a concentration of 10 to 100 Î¼M on"/>
  <result pre="Bax protein, caspase-3, and caspase-9. A significant proapoptotic effect of" exact="thymol" post="was found at a dose of 50 Î¼M. Genotoxicity"/>
  <result pre="a dose of 50 Î¼M. Genotoxicity tests have shown that" exact="thymol" post="concentration from 20 to 100 Î¼M induced DNA damage"/>
  <result pre="compared to control cells. Figure 7 presents a summary of" exact="thymol" post="antineoplastic activity pathways. 7. New Forms of Therapeutics Using"/>
  <result pre="[79] has shown that it is also possible to encapsulate" exact="thymol" post="and its derivatives into microcapsules made of natural polymers."/>
  <result pre="derivatives into microcapsules made of natural polymers. Good biocompatibility with" exact="thymol" post="is shown by lignin derivatives, especially lignosulfonate. The synergistic"/>
  <result pre="microvesicles with an efficiency up to 50%. A combination of" exact="thymol" post="and lignosulfonate was used on the controlled release system"/>
  <result pre="co-workers [80] examined the antibacterial activity and possibilities of sustained" exact="thymol" post="release from porous fibrous membrane made of cellulose acetate."/>
  <result pre="release from porous fibrous membrane made of cellulose acetate. Different" exact="thymol" post="membrane loads were used and the results were compared"/>
  <result pre="compared with non-porous membranes. Slower initial release and extended total" exact="thymol" post="release time in porous membranes were obtained. The highly"/>
  <result pre="aureus and E. coli. The highest activity was obtained with" exact="thymol" post="concentration of 15% (v/v), where the survival rate of"/>
  <result pre="the wall and membrane appeared in pathogen cells. Encapsulation of" exact="thymol" post="as the active ingredient of thyme EO into microspheres"/>
  <result pre="hydroxypropylmethylcellulose (HPMCP) were used. Although encapsulation into methylcellulose microspheres changes" exact="thymol" post="pharmacokineticsâ€&quot;shortening its half-lifeâ€&quot;it causes a significant increase in bioavailability"/>
  <result pre="causes a significant increase in bioavailability compared to the free" exact="thymol" post="form. This form may be beneficial during oral thymol"/>
  <result pre="free thymol form. This form may be beneficial during oral" exact="thymol" post="administration to obtain its systemic effect. HPMCP-based microcapsules were"/>
  <result pre="as well as their quantitative ratio. In order to control" exact="thymol" post="release, Zamani and co-workers [82] used mixtures of hydroxypropyl"/>
  <result pre="the destination. 7.3. Microfibres GÃ¡mez and co-workers [83] also studied" exact="thymol" post="for use in dressings to avoid infections that are"/>
  <result pre="studies on the advanced dressing, mesoporous silicon dioxide loaded with" exact="thymol" post="was incorporated into electrospun polycaprolactone microfibers (PCL). Tests conducted"/>
  <result pre="electrospun polycaprolactone microfibers (PCL). Tests conducted with dressing containing 5.6%" exact="thymol" post="were carried out using S. aureus, showing that this"/>
  <result pre="bactericidal concentration) values of mesoporous silicon dioxide particles loaded with" exact="thymol" post="were significantly lower than those previously found for the"/>
  <result pre="those previously found for the free form of thymol. Increased" exact="thymol" post="activity has been attributed to slower volatility, increased chemical"/>
  <result pre="confirms the broad spectrum of biological and therapeutic effects of" exact="thymol" post="and thyme EO. Antibiofilm action includes bacteria such as"/>
  <result pre="and HIV-1. In silico studies on the anti-Sars-CoV-2 activity of" exact="thymol" post="are also very promising. Unfortunately, the molecular mechanism of"/>
  <result pre="in vivo, and the therapeutic potential of thyme EO and" exact="thymol" post="in infectious diseases should be identified. Thymol also has"/>
  <result pre="apoptosis and inhibition of proliferation. New forms of medicines with" exact="thymol" post="or thyme EO, such as nanocapsules, can be very"/>
  <result pre="synthase gene (TPS2) as the major gene in biosynthesis of" exact="thymol" post="in different Thymus speciesPhytochemistry202016911212610.1016/j.phytochem.2019.11212631644985 7.BendifH.PeronG.MiaraM.D.SutS.Dallâ€™AcquaS.FlaminiG.MaggiF.Total phytochemical analysis of Thymus"/>
  <result pre="Phytochemicals against Rhizopus oryzae: Interaction with ErgosterolMolecules201217144181443310.3390/molecules17121441823519243 35.AhmadA.KhanA.AkhtarF.YousufS.XessI.KhanL.A.ManzoorN.Fungicidal activity of" exact="thymol" post="and carvacrol by disrupting ergosterol biosynthesis and membrane integrity"/>
  <result pre="Rhizopus oryzae: Interaction with ErgosterolMolecules201217144181443310.3390/molecules17121441823519243 35.AhmadA.KhanA.AkhtarF.YousufS.XessI.KhanL.A.ManzoorN.Fungicidal activity of thymol and" exact="carvacrol" post="by disrupting ergosterol biosynthesis and membrane integrity against CandidaEur."/>
  <result pre="against CandidaEur. J. Clin. Microbiol. Infect. Dis.201130415010.1007/s10096-010-1050-820835742 36.LioliosaC.C.GortzibO.LalasbS.TsaknisJ.ChinouaI.Liposomal incorporation of" exact="carvacrol" post="and thymol isolated from the essential oil of Origanum"/>
  <result pre="J. Clin. Microbiol. Infect. Dis.201130415010.1007/s10096-010-1050-820835742 36.LioliosaC.C.GortzibO.LalasbS.TsaknisJ.ChinouaI.Liposomal incorporation of carvacrol and" exact="thymol" post="isolated from the essential oil of Origanum dictamnus L."/>
  <result pre="potential biomedical applicationsMat. Sci. Eng. C202010911053610.1016/j.msec.2019.110536 81.RassuG.NiedduM.BosiP.TrevisiP.ColomboM.PrioriD.ManconiP.GiunchediP.GaviniE.BoattoG.Encapsulation and modified-release of" exact="thymol" post="from oral microparticles as adjuvant or substitute to current"/>
  <result pre="J. Pharm.20091112120 Figure 1 Scheme of the key steps of" exact="thymol" post="and carvacrol biosynthesis. Figure 2 The structure of the"/>
  <result pre="Figure 1 Scheme of the key steps of thymol and" exact="carvacrol" post="biosynthesis. Figure 2 The structure of the main components"/>
 </snippets>
</snippetsTree>
